Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 52 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

62%

32 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

52Total
Not Applicable (13)
Early P 1 (3)
P 2 (4)
P 3 (1)
P 4 (31)

Trial Status

Recruiting19
Completed16
Not Yet Recruiting10
Unknown5
Active Not Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (52)

Showing 20 of 20 trials
NCT07639099Phase 4Not Yet Recruiting

Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression

NCT07610343Phase 4Not Yet Recruiting

Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment

NCT07576517Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

NCT07576543Phase 4Not Yet Recruiting

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

NCT07230171Not ApplicableRecruiting

The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia

NCT07525999Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine Combination and Chronic Postsurgical Pain After Spinal Surgery

NCT07523334Phase 4Not Yet Recruiting

Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients

NCT07523321Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine Combination and Moderate-to-severe Pain After Spinal Surgery

NCT06062550Phase 4Active Not Recruiting

Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery

NCT07308756Phase 4Recruiting

Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery

NCT07145775Phase 4Completed

Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia

NCT07479602Phase 4Recruiting

Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients

NCT07247968Early Phase 1RecruitingPrimary

Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study

NCT05718024Phase 4Completed

Night-time Dexmedetomidine-esketamine Infusion and Sleep Quality in ICU Patients

NCT06853431Phase 4Recruiting

Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia

NCT07151716Phase 4Recruiting

Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients

NCT06530706Not ApplicableCompleted

Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery

NCT04425473Phase 2Completed

Esketamine and Perioperative Depressive Symptoms

NCT06399185Phase 4Recruiting

Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort

NCT05732064Phase 4Completed

Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Scroll to load more

Research Network

Activity Timeline